• No results found

DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC METHODS FOR THE ESTIMATION OF MICAFUNGIN IN BULK AND PHARMACEUTICAL FORMULATIONS

N/A
N/A
Protected

Academic year: 2020

Share "DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC METHODS FOR THE ESTIMATION OF MICAFUNGIN IN BULK AND PHARMACEUTICAL FORMULATIONS"

Copied!
6
0
0

Loading.... (view fulltext now)

Full text

(1)

INTERNATIONAL JOURNAL OF PHARMACEUTICAL, CHEMICAL AND BIOLOGICAL SCIENCES

Available online at

www.ijpcbs.com

DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC

METHODS FOR THE ESTIMATION OF MICAFUNGIN IN BULK AND

PHARMACEUTICAL FORMULATIONS

SM. Anil Kumar

*

, A. Satish Kumar Shetty and ND. Satyanarayan

Department of Pharmaceutical Analysis, National College of

Pharmacy, Shimoga-577 201, Karnataka, India.

INTRODUCTION

Micafungin (tradename Mycamine) {5-[(1S,2S)- 2-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-

3-[(1R)-2-carbamoyl-1-hydroxyethyl]- 11,20,21,25-tetrahydroxy-15-[(1R)-1- hydroxyethyl]-26-methyl-2,5,8,14,17,23- hexaoxo-18-(4-{5-[4-(pentyloxy)phenyl]-1,2- oxazol-3-yl}benzamido)-1,4,7,13,16,22- hexaazatricyclo[22.3.0.0⁹,¹³]heptacosan-6-yl]-

1,2-dihydroxyethyl]-2-hydroxyphenyl}oxidanesulfonicacidis

an echinocandin antifungal drug used to treat

and prevent invasive including candidemia, and abscesses and esophageal candidiasis.

Micafungin inhibits the synthesis of beta-1,3-D-glucan, an essential component of fungal cell walls which is not present in mammalian cells. It does this by inhibiting beta-1,3-D-glucan synthase1,2.

On literature survey it was revealed that several HPLC and UV or Mass spectrometric methods have been developed for the estimation of

micafungin in blood and plasma samples3,4,.

HPLC method for the estimation of micafungin

in related substances has been developed5.

Several methods have been reported on the

pharmacokinetic and saftey studies6. Since no

method has been found for the estimation of micafungin in bulk and pharmaceutical formulations, Here an attempt has been made to develop and validate simple , sensitive and precise UV Spectrophotometric methods for the estimation of micafungin in pure form and in formulation forms.

MATERIALS AND METHODS INSTRUMENTS USED

A double beam UV-VIS spectrophotometer (UV-1800, Shimadzu) connected to computer loaded with spectra manager software UV probe 2.4 with 10mm quartz cells was used. The spectra

were obtained with the instrumental

parameters as follows: wavelength range: 200-400nm. All weights were taken on electronic balance (Model Shimadzu AUX 120).

Research Article

ABSTRACT

The aim of present work was to develop an simple, accurate and precise zero order derivative method and First order derivative method for the estimation of Micafungin and validation according to ICH Q2(R1) guidelines. The absorbance maxima was determined at 269nm using Distilled Water .First order derivative spectrophotometric method has been developed at wavelength 249nm. The

methods represented the correlation coefficient R2 = 0.999 for zero order method and R2 = 0.999

for First order derivative at concentration range 8-40µg/ml for both methods.The methods were validated for the parameters such as linearity, accuracy, precision, limit of quantification & limit of detection as per ICH guidelines. The results suggested that the proposed methods were found to be cost effective, sensitive, precise and accurate and hence can be successfully applied for the routine analysis of Micafungin in bulk and formulations.

(2)

Standard stock solution

Micafungin (100mg) was accurately weighed and transferred in a 100ml volumetric flask. Volume was made up to 100ml with distilled water to obtain a concentration of 1000μg/ml (Stock-I). From Stock-I 10 ml of solution was withdrawn and transferred to a 100ml volumetric flask and made up the volume with distilled water to obtain a concentration of 100μg/ml (Stock-II). From the above stock

solution-II aliquots of 0.8ml, 1.6ml, 2.4ml, 3.2ml,

and 4ml were withdrawn and transferred into 10 ml volumetric flasks and made up the volume with distilled water to obtain a concentrations of 8µg/ml, 16µg/ml, 24µg/ml, 32µg/ml, and 40µg/ml respectively.

Determination of maximum wavelength

Micafungin 8-40 µg/ml solutions were scanned in UV spectrophotometer in the range of 200-400nm by using Distilled water as blank.

Preparation of standard calibration curve Zero order derivative

The standard calibration curve was obtained by measuring the absorbance of Micafungin solution in concentration range (8-40µg/ml) prepared from stock solutions in Distilled Water at 269nm . Calibration curve of Micafungin was plotted with absorbance on y-axis and Micafungin concentration on x-axis.

First order derivative spectroscopy

In this method solutions of Micafungin (8-40μg/ml) were prepared separately by appropriate dilution of standard stock solution and scanned in the spectrum mode from 200 to 400 nm. The absorption spectra obtained were derivatized to first order derivative peaks by taking scaling factor 100 and delta lambda 4. First order derivative spectra were selected for analysis of drug. The absorbance was measured at wavelength 249 nm for the respective concentration of standard and plotted against concentration and absorbance and regression equation was calculated.

RESULTS VALIDATION

The developed methods were validated as per ICH guidelines.

Linearity

The linearity was determined by using working

standard solution between 8-40µg/ml.

Absorbance values of these solutions were measured at wavelength 269nm in zero order and at 249nm in first order method. The value of

correlation coefficient for Micafungin

demonstrated the good relationship between absorbance and concentrations. Therefore, the developed methods were linear in concentration range of 8-40μg/ml.

Accuracy

The accuracy of the method was determined by calculating percent recovery of the drug by standard addition method. Percent recovery of Micafungin was determined at three different level 80%, 100% and 120% of the target concentration in triplicate absorbance was measured at wavelength 269nm for Zero order method and at 249nm for first order derivative method.

Precision

Precision of the methods were demonstrated by intraday and inter day variation studies. In Intraday variation , 24μg/ml of Micafungin solution was analysed six times in a day and the absorbance values were noted. From the parameters mean, Standard deviation were calculated. The acceptable limit for intraday variation should be within 2% and results shown in table 5 and 6 indicate the drug complied with the required limit.

In Interday variation studies, solution of 16μg/ml of Micafungin was analysed six times a day for three consecutive days and absorbance values were recorded.

LOD and LOQ

Limit of detection (LOD) is the lowest amount of analyte in the sample that can be detected. Limit of Quantification (LOQ) is the lowest amount of analyte in the sample that can be quantitatively determined by suitable precision and accuracy. LOD and LOQ were determined using the following equation.

LOQ =

LOD = 3.3

Where s is the standard deviation of the response and m is the slope of the related calibration curve. The LOD and LOQ were found to be 0.543 and 1.6454 for zero order derivative method .

The LOD and LOQ were found to be 0.7031 and 2.1307 respectively for First order derivative method.

DISCUSSION

The proposed methods provides a simple, accurate, economical and convenient methods for the analysis of Micafungin using UV

spectrophotometry. The wavelength

(3)

order and 269nm in first order derivative method. Beer’s law was obeyed in the concentration range of 8-40 µg/ml for both the methods with correlation coefficient 0.999. Accuracy of the proposed methods were determined by recovery studies, a good % recovery (99.08-100.09 % for Zero order method and 99.93-100.05 % for First order derivative method ) of the drug obtained indicates that the methods are accurate. The methods were found to be precise as %RSD values for interday and intraday was found to be less than 2%. The limit of detection and limit of quantification of the proposed zero order method was found to be 0.543 and 1.6454 respectively and for the First order derivative method was found to be 0.7031 and 2.1307 respectively. The results of the analysis of

pharmaceutical formulation by the developed methods was consistent with the label claim, highly reproducible and reliable.

CONCLUSION

The developed UV spectrophotometric methods for the estimation of Micafungin is simple, sensitive ,and economical. These methods were also validated by checking the parameters such as accuracy, precision, linearity, LOD and LOQ. The proposed methods showed high level of precision as depicted by low values of standard deviation and relative standard deviation. Hence these methods can be used for routine analysis of Micafungin in bulk and pharmaceutical formulations without interference of excipients and other additives.

Fig. 1: Structure of Micafungin

Fig. 2: Overlay Spectrum of Micafungin at 269nm (Zero order method)

nm .

200.00 250.00 300.00 350.00 400.00

Ab

s.

1.100

1.000

0.500

(4)

Fig. 3: Overlay Spectrum of Micafungin at 249nm (First order derivative)

Fig. 4 : Calibration curve of Micafungin for Zero order method

nm.

202.21 250.00 300.00 371.32

A

b

s.

4.900

4.000

2.000

0.000

-2.000

-4.000

-4.841

y = 0.0253x - 0.0043 R² = 0.9993

0 0.2 0.4 0.6 0.8 1 1.2

0 10 20 30 40 50

Concentration

Abs

or

ba

nce

(5)

Fig. 5: Calibration curve of Micafungin for first order derivative

Table 1: Linearity profile of Micafungin for Zero order derivative

Sr.No Concentration (µg/ml) 269.0 nm± S.D. Absorbance at

1 8 0.203±0.00850

2 16 0.401±0.00519

3 24 0.599±0.00264

4 32 0.794±0.00461

5 40 1.019±0.02137

Table 2: Linearity profile of Micafungin for First order derivative Sr.No Concentration (µg/ml) 269.0 nm± S.D. Absorbance at

1 8 0.542±0.01389

2 16 1.029±0.01443

3 24 1.546±0.00964

4 32 2.056±0.01069

5 40 2.635±0.05533

Table 3: Recovery studies for Zero order Derivative Level of %

recovery Mean* Deviation* Standard %RSD

80% 99.08 0.08333 0.08410

100% 99.88 0.23867 0.23895

120% 100.09 0.33942 0.33911

Table 4: Recovery studies for First order Derivative Level of %

recovery Mean* Deviation* Standard %RSD

80% 99.93 0.37807 0.37833

100% 99.98 0.17769 0.17771

120% 100.05 0.21262 0.21249

y = 0.0652x - 0.0023 R² = 0.9991

0 0.5 1 1.5 2 2.5 3

0 10 20 30 40 50

Concentration

Abs

or

ba

nce

(6)

Table 5: Statistical data of precision by Zero order derivative method

Component Precision Mean* Standard Deviation* % RSD

Micafungin Intra-day 99.86 0.331700 0.33215

Inter-day 100.08 0.05653 0.05648

Table 6: Statistical data of precision by First order derivative method

Component Precision Mean* Standard Deviation* % RSD

Micafungin Intra-day 100.01 0.14593 0.14591

Inter-day 100.02 0.22381 0.22376

Table 7: Summary of the methods developed (Zero order derivative and First order derivative)

Parameter Results

Zero order method First order derivative

Absorption maxima 269nm 249 nm

Beers law range 8-40 µg/ml 8-40 µg/ml

Correlation coefficient 0.999 0.999

Regression equation Y= 0.025x-0.004 Y=0.065x-0.002

Slope 0.025 0.065

Intercept 0.004 0.002

Accuracy 99.08-100.09% 99.93-100.05%

Precision (%RSD) Intraday - 0.33215 Intraday – 0.14591

Interday – 0.05648 Interday – 0.22376

LOD µg/ml 0.543 0.7031

LOQ µg/ml 1.6454 2.1307

REFERENCES

1. https://en.wikipedia.org/wiki/Micafun

gin.

2. https://www.drugbank.ca/drugs/DB01

141

3. Lobenhoffer JM, Rupprecht V, Stefanie

M and Boger B. Determination of micafungin and anidulafungin in human plasma: UV- or mass spectrometric quantification. J of chromatography B. 2011;879:2051-6.

4. Talviya S and Majmudar F. Analysis of

antifungal agents by RP-HPLC: a review. WJPPS. 2014; 3:397-409.

5. Zhu S, Meng X, Su X, Luo Y and Z Sun.

Development and validation of

stability-indicating HPLC method for

determination of related substances of Micafungin Sodium in drug substances.

Int J of Molecular sciences.

2013;14(11):21202-14.

6. Gloria HP, Dale GR, Michael RD, John

NVA and Blumer. The pharmacokinetics and safety of Micafungin, a novel Echinocandin, in premature infants. J of Paediatric infectious disease. 2006; 25:1110-5.

7. ICH, Harmonised Tripartite Guideline,

Figure

Fig. 1: Structure of Micafungin
Fig. 3: Overlay Spectrum of Micafungin at nm.
Fig. 5: Calibration curve of Micafungin for  first order derivative
Table 5: Statistical data of precision by  Zero order derivative  method Component Precision Mean* Standard Deviation*

References

Related documents

Corroborating their strong desire to ensure patients were informed were HCPs concerns that the ever- increasing mainstream specialities now ordering genetic tests might not grasp

The purpose of this study is to characterize the very eld- erly population, who received emergency general surgery, and examine their surgical outcomes including identifica- tion

columnare bacterial cell aggre- gates around goblet cells in common carp [11] and catfish [43] following experimental challenge with a highly virulent strain [76].. Beck

suis cells were detected on PAECs incubated with the negative control preparation (Figure 5d).. To assess whether the presence

Yet the story presented by Skloot had the potential to generate a broader discussion in the media and among the public about the ethical concerns related to biobanks and

We used a thematic analysis [50] to summarize respondents ’ major thoughts and concerns about post-mortem needle biop- sies, including acceptable motivations for conducting

However, the nanosilver-coated orthodontic bracket can be utilized during fixed orthodontic treatment with caution, because the foreign particles which are brown-black granules

Summary: This paper proposes that ethics education has a new contribution to make, in supporting and promoting ethical practice – as it is defined in and by the everyday actions